Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice

Carcinogenesis

Volumn 36, Issue 11, 2015, Pages 1388-1396

  Dingemanse, Celia ^a   Belzer, Clara ^b   van Hijum, Sacha A F T ^c,d   Günthel, Marie ^a   Salvatori, Daniela ^a   den Dunnen, Johan T ^a   Kuijper, Ed J ^a   Devilee, Peter ^a   de Vos, Willem M ^b,e   van Ommen, GertJan B ^a   Robanus Maandag, Els C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NIZO FOOD RESEARCH   (Netherlands)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; RNA 16S; ANTIINFECTIVE AGENT;

AKKERMANSIA MUCINIPHILA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CITROBACTER RODENTIUM; COLONY FORMING UNIT; COLORECTAL TUMOR; CONTROLLED STUDY; CORYNEBACTERIUM KUTSCHERI; FEMALE; GASTROINTESTINAL DISEASE; HELICOBACTER; HELICOBACTER HEPATICUS; HELICOBACTER TYPHLONIUS; HISTOLOGY; HISTOPATHOLOGY; INTESTINE TUMOR; MALE; METAGENOMICS; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PASTEURELLACEAE; PHYLOGENY; REAL TIME POLYMERASE CHAIN REACTION; SALMONELLA; STREPTOCOCCUS PNEUMONIAE; TUMOR GROWTH; ANIMAL; C57BL MOUSE; CARCINOGENESIS; COMBINATION DRUG THERAPY; COMPLICATION; DRUG EFFECTS; GOBLET CELL; HELICOBACTER INFECTIONS; INTESTINAL NEOPLASMS; INTESTINE; INTESTINE FLORA; MICROBIOLOGY; PATHOLOGY; VERRUCOMICROBIA;

AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; CARCINOGENESIS; CLARITHROMYCIN; DRUG THERAPY, COMBINATION; FEMALE; GASTROINTESTINAL MICROBIOME; GOBLET CELLS; HELICOBACTER; HELICOBACTER INFECTIONS; INTESTINAL NEOPLASMS; INTESTINES; MALE; METRONIDAZOLE; MICE, INBRED C57BL; OMEPRAZOLE; VERRUCOMICROBIA;

EID: 84984551811     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgv120     Document Type: Article

References (46)

1. Qin, J. et al. (2010) A human gut microbial gene catalogue established by metagenomic sequencing. Nature, 464, 59–65.
2. Lozupone, C.A. et al. (2012) Diversity, stability and resilience of the human gut microbiota. Nature, 489, 220–230.
3. Arthur, J.C. et al. (2011) The struggle within: microbial influences on colorectal cancer. Inflamm. Bowel Dis., 17, 396–409.
4. Kabir, S. (2009) Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models: underlying biochemical and molecular events. Helicobacter, 14, 159–171.
5. Boleij, A. et al. (2012) Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biol. Rev. Camb. Philos. Soc., 87, 701–730.
6. Garrett, W.S. et al. (2009) Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer Cell, 16, 208–219.
7. Uronis, J.M. et al. (2009) Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One, 4, e6026.
8. Wu, S. et al. (2009) A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med., 15, 1016–1022.
9. Arthur, J.C. et al. (2012) Intestinal inflammation targets cancer-inducing activity of the microbiota. Science, 338, 120–123.
10. Erdman, S.E. et al. (2003) CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am. J. Pathol., 162, 691–702.
11. Maggio-Price, L. et al. (2006) Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer Res., 66, 828–838.
12. Rao, V.P. et al. (2006) Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res., 66, 7395–7400.
13. Nagamine, C.M. et al. (2008) Helicobacter hepaticus infection promotes colon tumorigenesis in the BALB/c-Rag2(-/-) Apc(Min/+) mouse. Infect. Immun., 76, 2758–2766.
14. Erdman, S.E. et al. (2009) Nitric oxide and TNF-alpha trigger colonic inflammation and carcinogenesis in Helicobacter hepaticusinfected, Rag2-deficient mice. Proc. Natl. Acad. Sci. USA, 106, 1027–1032.
15. Li, Y. et al. (2012) Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APCMin/+ mice. Carcinogenesis, 33, 1231–1238.
16. Dulal, S. et al. (2014) Gut microbiome and colorectal adenomas. Cancer J., 20, 225–231.
17. Marchesi, J.R. et al. (2011) Towards the human colorectal cancer microbiome. PLoS One, 6, e20447.
18. Castellarin, M. et al. (2012) Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res., 22, 299–306.
19. Kostic, A.D. et al. (2012) Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res., 22, 292–298.
20. Kostic, A.D. et al. (2013) Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe, 14, 207–215.
21. Robanus-Maandag, E.C. et al. (2010) A new conditional Apc-mutant mouse model for colorectal cancer. Carcinogenesis, 31, 946–952.
22. Koelink, P.J. et al. (2009) 5-Aminosalicylic acid inhibits colitis-associated but not sporadic colorectal neoplasia in a novel conditional Apc mouse model. Carcinogenesis, 30, 1217–1224.
23. Fox, J.G. et al. (1999) A novel urease-negative Helicobacter species associated with colitis and typhlitis in IL-10-deficient mice. Infect. Immun., 67, 1757–1762.
24. Franklin, C.L. et al. (2001) Helicobacter typhlonius sp. nov., a Novel Murine Urease-Negative Helicobacter Species. J. Clin. Microbiol., 39, 3920–3926.
25. Derrien, M. et al. (2004) Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int. J. Syst. Evol. Microbiol., 54(Pt 5), 1469–1476.
26. Chichlowski, M. et al. (2008) Helicobacter typhlonius and Helicobacter rodentium differentially affect the severity of colon inflammation and inflammation-associated neoplasia in IL10-deficient mice. Comp. Med., 58, 534–541.
27. Everard, A. et al. (2013) Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA, 110, 9066–9071.
28. Out, A.A. et al. (2009) Deep sequencing to reveal new variants in pooled DNA samples. Hum. Mutat., 30, 1703–1712.
29. Altschul, S.F. et al. (1990) Basic local alignment search tool. J. Mol. Biol., 215, 403–410.
30. Mitra, S. et al. (2009) Visual and statistical comparison of metagenomes. Bioinformatics, 25, 1849–1855.
31. Feng, S. et al. (2005) Differential detection of five mouse-infecting helicobacter species by multiplex PCR. Clin. Diagn. Lab. Immunol., 12, 531–536.
32. Collado, M.C. et al. (2007) Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl. Environ. Microbiol., 73, 7767–7770.
33. Everard, A. et al. (2011) Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes, 60, 2775–2786.
34. Geurts, L. et al. (2011) Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front. Microbiol., 2, 149.
35. Derrien, M. et al. (2008) The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl. Environ. Microbiol., 74, 1646–1648.
36. Belzer, C. et al. (2012) Microbes inside–from diversity to function: the case of Akkermansia. ISME J., 6, 1449–1458.
37. Colnot, S. et al. (2004) Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers. Lab. Invest., 84, 1619–1630.
38. Shin, N.R. et al. (2014) An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut, 63, 727–735.
39. Ganesh, B.P. et al. (2013) Commensal Akkermansia muciniphila exacerbates gut inflammation in Salmonella typhimurium-infected gnotobiotic mice. PLoS One, 8, e74963.
40. Stecher, B. et al. (2007) Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol., 5, 2177–2189.
41. Ganesh, B.P. et al. (2012) Enterococcus faecium NCIMB 10415 does not protect interleukin-10 knock-out mice from chronic gut inflammation. Benef. Microbes, 3, 43–50.
42. Weir, T.L. et al. (2013) Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults. PLoS One, 8, e70803.
43. Sanapareddy, N. et al. (2012) Increased rectal microbial richness is associated with the presence of colorectal adenomas in humans. ISME J., 6, 1858–1868.
44. Salonen, A. et al. (2014) Impact of diet on human intestinal microbiota and health. Annu. Rev. Food Sci. Technol., 5, 239–262.
45. Zackular, J.P. et al. (2013) The gut microbiome modulates colon tumorigenesis. MBio, 4, e00692–e00613.
46. Baxter, N.T. et al. (2014) Structure of the gut microbiome following colonization with human feces determines colonic tumor burden. Microbiome, 2, 20.